trimetoprim viatris 10 mg/ml oral suspension
viatris ab - trimetoprim - oral suspension - 10 mg/ml - xylitol hjälpämne; sorbitol hjälpämne; metylparahydroxibensoat hjälpämne; trimetoprim 10 mg aktiv substans; propylparahydroxibensoat hjälpämne - trimetoprim
flukloxacillin viatris 1 g filmdragerad tablett
viatris ab - flukloxacillinnatriummonohydrat - filmdragerad tablett - 1 g - flukloxacillinnatriummonohydrat 1090 mg aktiv substans
apixaban viatris 5 mg filmdragerad tablett
viatris limited - apixaban - filmdragerad tablett - 5 mg - laktosmonohydrat hjälpämne; natriumlaurilsulfat hjälpämne; apixaban 5 mg aktiv substans; laktos (vattenfri) hjälpämne
apixaban viatris 2,5 mg filmdragerad tablett
viatris limited - apixaban - filmdragerad tablett - 2,5 mg - natriumlaurilsulfat hjälpämne; laktosmonohydrat hjälpämne; laktos (vattenfri) hjälpämne; apixaban 2,5 mg aktiv substans
icatibant viatris 30 mg injektionsvätska, lösning i förfylld spruta
viatris limited - ikatibantacetat - injektionsvätska, lösning i förfylld spruta - 30 mg - ikatibantacetat 31,38 mg aktiv substans
cabazitaxel viatris 20 mg/ml koncentrat till infusionsvätska, lösning
viatris limited - kabazitaxel - koncentrat till infusionsvätska, lösning - 20 mg/ml - etanol, vattenfri hjälpämne; kabazitaxel 20 mg aktiv substans
vancomycin viatris 1000 mg pulver till infusionsvätska, lösning
viatris limited - vankomycinhydroklorid - pulver till infusionsvätska, lösning - 1000 mg - vankomycinhydroklorid 1025 mg aktiv substans
vancomycin viatris 500 mg pulver till infusionsvätska, lösning
viatris limited - vankomycinhydroklorid - pulver till infusionsvätska, lösning - 500 mg - vankomycinhydroklorid 512,76 mg aktiv substans
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotiska medel - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
losartan viatris 100 mg filmdragerad tablett
viatris limited - losartankalium - filmdragerad tablett - 100 mg - laktosmonohydrat hjälpämne; losartankalium 100 mg aktiv substans - losartan